Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Secretome vs PRP for Androgenetic Alopecia
NCT07429253Phase 2Recruiting
- Sponsor
- Prodia Stem Cell Indonesia
- Start
- Jan 2026
- Primary completion
- Jun 2026
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cell secretome in androgenetic alopecia (AGA), sponsored by Prodia Stem Cell Indonesia. Started Jan 2026; status: recruiting.
02
Drugs
human umbilical cord mesenchymal stem cell secretome
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT07429253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07429253.